PErsistence and Safety of Subcutaneous Infliximab 1 Year after Switch from Intravenous Route in IBD Patients in REMission.
Nicolas Mathieu, Marianne Hupé,Frédéric Heluwaert,Pauline Rivière,Xavier Hébuterne,Antoine Chupin,Vered Abitbol,Guillaume Bouguen,Lucine Vuitton,Jean-Marc Gornet, Céline Montuclard,Stéphane Nancey, Guillaume Cadiot,Pauline Wils,Cyrielle Gilletta, Astrid de Maissin, Romain Altwegg, Elise Chanteloup,Laurianne Plastaras, Philippe Ah Soune,Arnaud Bourreille,Carmen Stefanescu,Philippe Seksik, Marion Simon,Mathieu Uzzan, Pierre Andrau, Cléa Rouillon, Yves Arondel,Anthony Buisson,Laurent Peyrin-Biroulet, Bassirou Mboup,Eric Vicaut,David Laharie Clinical gastroenterology and hepatology the official clinical practice journal of the American Gastroenterological Association（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper